March 3, 2026 · Form 4 insider transaction
Poole Jonathan bought 4,218 shares of ACADIA Pharmaceuticals Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 17 days after the transaction.
Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.; The restricted stock units will vest in equal annual installments over three years following the date of grant such that the restricted stock units will be fully vested on the third anniversary of the date of grant.